Wall Street Analysts Think Phathom Pharmaceuticals (PHAT) Could Surge 87.21%: Read This Before Placing a BetZacks Investment Research • 08/22/25
Phathom Pharmaceuticals Clarifies That There Is No Reduction in Lead Shareholder's Ownership Following Administrative Change to 13D FilingGlobeNewsWire • 08/20/25
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/07/25
Phathom Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business UpdatesGlobeNewsWire • 08/07/25
Phathom Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide Business Update on Thursday, August 7, 2025GlobeNewsWire • 07/28/25
Phathom Pharmaceuticals: Potential Blockbuster Gastric Acid-Reducing Drug With New MechanismSeeking Alpha • 06/25/25
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 06/23/25
Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate SecretaryGlobeNewsWire • 06/23/25
Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032GlobeNewsWire • 06/16/25
Tiny Phathom Pharmaceuticals Just An Got FDA Blessing And Big-Time Upside: BuySeeking Alpha • 06/10/25
Wall Street Analysts Believe Phathom Pharmaceuticals (PHAT) Could Rally 107.4%: Here's is How to TradeZacks Investment Research • 06/09/25
Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032GlobeNewsWire • 06/06/25
After Plunging -45.82% in 4 Weeks, Here's Why the Trend Might Reverse for Phathom Pharmaceuticals (PHAT)Zacks Investment Research • 05/08/25
Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business UpdateGlobeNewsWire • 05/01/25
Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2025 Annual MeetingGlobeNewsWire • 04/28/25
Phathom Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide Business Update on Thursday, May 1, 2025GlobeNewsWire • 04/23/25
Phathom Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/03/25
Actor and Comedian Kenan Thompson Teams Up with Phathom Pharmaceuticals to Raise Awareness About GERD and VOQUEZNA® (vonoprazan)GlobeNewsWire • 03/31/25